| Followers | 1520 |
| Posts | 89014 |
| Boards Moderated | 5 |
| Alias Born | 05/09/2004 |
Tuesday, October 10, 2017 1:06:08 AM
Armando Anido
Chairman of the Board and Chief Executive Officer
Most recently, he was the CEO of NuPathe (NASDAQ: PATH), which was acquired by Teva Pharmaceuticals in February 2014. At NuPathe, he led the company through FDA approval of its lead product, Zecuity®, the first transdermal patch for migraine, to pre-launch before successfully selling the company to Teva.
http://zynerba.com/about-us-2/management
ZYNE
David Dalton CEO, CFO, Principal Acct. Officer of UNVC
http://www.blackengineer.com/article/where-the-jobs-are-biopharmaceuticals
>>> http://pharmacy.hsc.wvu.edu/about-the-sop/centennial-hall-of-fame/hall-of-fame-inductees
Something BIG is going on here https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135267742
A lot of big people in the Medical industry connected here
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
